Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Niaspan proves safe and effective in diabetics

Nov. 24, 2000

Suntory and Chugai to codevelop rhPTH(1-34) for osteoporosis

Nov. 24, 2000

Schering AG and Population Council establish MENT collaboration

Nov. 24, 2000

NPY receptor ligands synthesized at Meiji Seika reduce food intake in animals

Nov. 23, 2000

New oxytocin antagonists in development at Ferring for use in preterm labor, menstrual pain

Nov. 23, 2000

CV Therapeutics reports potential strategy for raising HDL cholesterol

Nov. 23, 2000

Lipitor reduces ischemic events following ACS

Nov. 22, 2000

Antidiabetic imidazoles in the Sankyo pipeline

Nov. 21, 2000

Dose-dependent decreases in serum uric acid levels demonstrated for TMX-67 in early clinical trial

Nov. 21, 2000

Recently issued patent covers Meiji Seika's new lipid-lowering agents

Nov. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...